Antibiotic prophylaxis for patients with newly diagnosed multiple myeloma: Systematic review and meta-analysis.
Ghulam Rehman MohyuddinMuhammad AzizBrian McCluneAl-Ola AbdallahMuzaffar QazilbashPublished in: European journal of haematology (2020)
Antibiotic prophylaxis for a finite duration can decrease the overall incidence of infection within the first 3 months following diagnosis. This does not lead to a decrease in mortality. Further data on antibiotic resistance patterns, toxicity, healthcare expenditures, and the impact of antibiotics on subsequent therapies can assist providers in helping make decisions on prophylactic antibiotics with their patients.
Keyphrases
- newly diagnosed
- healthcare
- end stage renal disease
- multiple myeloma
- ejection fraction
- risk factors
- chronic kidney disease
- oxidative stress
- prognostic factors
- peritoneal dialysis
- electronic health record
- big data
- cardiovascular disease
- health insurance
- machine learning
- social media
- deep learning
- health information
- patient reported